Dual GIP & GLP-1 Receptor Agonist Peptide
A synthetic peptide engineered as a dual GIP and GLP-1 receptor agonist. Utilized to investigate synergistic incretin receptor binding and its effects on intracellular cAMP production.
A synthetic peptide engineered as a dual GIP and GLP-1 receptor agonist. Utilized to investigate synergistic incretin receptor binding and its effects on intracellular cAMP production.
A modified GLP-1 structural analogue featuring a fatty acid side chain, designed to study enzymatic resistance, extended half-life, and pancreatic beta-cell interaction in controlled laboratory models.
A dual-action combination stack utilized to study the synergistic effects of GHRH receptor agonism (CJC-1295) and selective ghrelin receptor agonism (Ipamorelin) on the somatotropic axis.
A synthetic, non-selective agonist of the melanocortin receptors. Provided as a research reagent to study melanogenesis processes, cellular pigmentation models, and neuroendocrine pathways in-vitro.